The value of 18F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors

18F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma

(2012) Akram Al-Ibraheem et al.   CANCER

18F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy

(2012) K. Herrmann et al.   CLINICAL CANCER RESEARCH

Effect of PET/CT on Management of Patients with Non-Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data

(2012) D. L. Gregory et al.   JOURNAL OF NUCLEAR MEDICINE

PET/CT Allows Stratification of Responders to Neoadjuvant Chemotherapy for High-Grade Sarcoma

(2011) Ukihide Tateishi et al.   CLINICAL NUCLEAR MEDICINE

The utility of PET/CT in staging and assessment of treatment response of nasopharyngeal cancer

(2011) Alastair Law et al.   Journal of Medical Imaging and Radiation Oncology

Positron Emission Tomography With [18F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study

(2010) Max Lonneux et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma

(2009) Seung Hyup Hyun et al.   ANNALS OF SURGICAL ONCOLOGY

Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

(2009) Matthias R. Benz et al.   CANCER

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

(2009) M. R. Benz et al.   CLINICAL CANCER RESEARCH

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas

(2008) V. Evilevitch et al.   CLINICAL CANCER RESEARCH

[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study

(2007) R. E. Ferner et al.   ANNALS OF ONCOLOGY